Proton pump inhibitor treatment for congenital chloride diarrhea.
Division of Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, Lucile Packard Children's Hospital at Stanford, Stanford University Medical Center, 750 Welch Road Suite 116, Palo Alto, CA 94304-0126, USA.
Kevin P
KP
Pieroni
Dorsey
D
Bass
D000328:Adult; D000653:Amniotic Fluid; D001623:Betamethasone / Q000627:therapeutic use; D027963:Chloride-Bicarbonate Antiporters / Q000235:genetics / Q000378:metabolism*; D036861:Delivery, Obstetric; D003967:Diarrhea / Q000151:congenital / Q000188:drug therapy / Q000235:genetics; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007037:Hypothyroidism / Q000188:drug therapy; D007231:Infant, Newborn; D008279:Magnetic Resonance Imaging; D008661:Metabolism, Inborn Errors / Q000188:drug therapy / Q000235:genetics; D009853:Omeprazole / Q000627:therapeutic use; D006831:Polyhydramnios / Q000175:diagnosis; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy* / Q000235:genetics; D054328:Proton Pump Inhibitors / Q000627:therapeutic use*; D013974:Thyroxine / Q000627:therapeutic use; D015145:Tocolysis; D016896:Treatment Outcome; D016216:Ultrasonography, Prenatal
D027963:Chloride-Bicarbonate Antiporters; D054328:Proton Pump Inhibitors; D001623:Betamethasone; D009853:Omeprazole; D013974:Thyroxine